150 related articles for article (PubMed ID: 4015182)
1. Activation of complement by 405-nm light in serum from porphyria cutanea tarda.
Torinuki W; Miura T; Tagami H
Arch Dermatol Res; 1985; 277(3):174-8. PubMed ID: 4015182
[TBL] [Abstract][Full Text] [Related]
2. Activation of the complement system in patients with porphyrias after irradiation in vivo.
Lim HW; Poh-Fitzpatrick MB; Gigli I
J Clin Invest; 1984 Dec; 74(6):1961-5. PubMed ID: 6392339
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative complement pathway by 405 nm light in serum from porphyric rat.
Torinuki W; Miura T; Tagami H
Acta Derm Venereol; 1984; 64(5):367-72. PubMed ID: 6208712
[TBL] [Abstract][Full Text] [Related]
4. Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light.
Lim HW; Perez HD; Goldstein IM; Gigli I
J Clin Invest; 1981 Apr; 67(4):1072-7. PubMed ID: 7204567
[TBL] [Abstract][Full Text] [Related]
5. Complement cleavage products in the phototoxic reaction of porphyria cutanea tarda.
Pigatto PD; Polenghi MM; Altomare GF; Giacchetti A; Cirillo R; Finzi AF
Br J Dermatol; 1986 May; 114(5):567-73. PubMed ID: 3487340
[TBL] [Abstract][Full Text] [Related]
6. Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda.
Lim HW; Perez HD; Poh-Fitzpatrick M; Goldstein IM; Gigli I
N Engl J Med; 1981 Jan; 304(4):212-6. PubMed ID: 7442746
[No Abstract] [Full Text] [Related]
7. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
Kew RR; Webster RO
J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in type 1 human diabetes.
Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
[TBL] [Abstract][Full Text] [Related]
9. Activation of the alternative complement pathway by Fonsecaea pedrosoi.
Torinuki W; Okohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1984 Oct; 83(4):308-10. PubMed ID: 6481182
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic action of uroporphyrin on the complement system in porphyria cutanea tarda.
Meurer M; Schulte C; Weiler A; Goerz G
Arch Dermatol Res; 1985; 277(4):293-8. PubMed ID: 3923948
[TBL] [Abstract][Full Text] [Related]
12. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
Lim HW
Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietic protoporphyria. Photoactivation of the complement system.
Gigli I; Schothorst AA; Soter NA; Pathak MA
J Clin Invest; 1980 Sep; 66(3):517-22. PubMed ID: 7400327
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
17. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
[TBL] [Abstract][Full Text] [Related]
18. The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber.
Håkansson L; Venge P
Scand J Immunol; 1984 Jan; 19(1):63-73. PubMed ID: 6367020
[TBL] [Abstract][Full Text] [Related]
19. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
[TBL] [Abstract][Full Text] [Related]
20. Stratum corneum activation of complement through the antibody-independent alternative pathway.
Terui T; Kato T; Tagami H
J Invest Dermatol; 1989 Apr; 92(4):593-7. PubMed ID: 2649596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
